Innovative Chemical Approach Revitalizes Malaria Drug Effectiveness

Researchers have pioneered a chemical modification that enhances the solubility and efficacy of a malaria drug, offering new hope against resistant strains. Learn how this breakthrough could revolutionize malaria treatment.
Researchers at the University of California, San Francisco, have discovered a novel chemical modification that transforms a once-failing malaria medication into a potent, easy-to-administer drug. Malaria remains a global health challenge, claiming approximately 600,000 lives annually, predominantly children in Sub-Saharan Africa. The increasing resistance of the malaria parasite to existing treatments has necessitated the development of new therapies.
The team focused on artefenomel, an artemisinin-inspired compound originally designed to replace combination therapies due to its potential to cure malaria with a single dose. However, clinical trials revealed significant challenges: artefenomel's high symmetry caused it to form crystals, hindering its dissolution and making it difficult to develop as a practical oral pill. It also proved problematic in pediatric treatments, where the suspension form was hard for children to swallow and ensure accurate dosing.
To address these issues, scientists manipulated the molecular structure, reducing its symmetry to prevent crystallization and enhance solubility. The modified molecules dissolved instantaneously in water, facilitating easier formulation into pills. Subsequent testing confirmed that these new compounds remained highly effective against malaria parasites, including strains resistant to artemisinin, and could be produced inexpensively.
This breakthrough offers hope for more effective, accessible malaria treatments, especially critical as resistance spreads into Africa, where most cases and fatalities occur. The findings suggest that simple chemical tweaks can revitalize existing drugs, providing a new path forward in the fight against resistant malaria strains.
The research has been published in Science Advances and signifies a promising step towards developing more reliable and straightforward antimalarial medications.
Source: https://medicalxpress.com/news/2025-08-chemical-malaria-drug-winner.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Framework Developed for Analyzing Metabolic Data to Predict Disease Risks
A new mathematical framework for analyzing large-scale metabolic data enhances disease risk prediction and personalized healthcare by revealing meaningful metabolic patterns and subgroups.
Innovative Dual-Target CAR-T Cells Show Promise Against T-ALL Leukemia in Preclinical Studies
New dual-target CAR-T cell therapy shows promising preclinical results against T-ALL leukemia by targeting unique markers, paving the way for more effective treatments.
Understanding How Viruses Exploit Weaknesses in Antibody Defense
Recent research reveals how SARS-CoV-2 develops mutations to evade monoclonal antibody treatments. Combining multiple antibodies could prevent viral escape and improve therapeutic efficacy.
Preventing Medicine-Related Poisoning in Children: The Risks of Paracetamol and Safe Use
A new report highlights that nearly 100 children in Australia are hospitalized daily due to medication poisoning, with many incidents preventable through proper medication use and safety measures. Learn how to protect children from common medicine-related risks.



